Single User License
INR 136740
Site License
INR 273480
Corporate User License
INR 410220

Service Tax Additional

select a format
Price

Single User License
USD 2000
Site License
USD 4000
Corporate User License
USD 6000

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"

Ken Research completed the report successfully with tough deadline and large requirement. Really appreciate it... "Sales Manager, Largest India Aesthetic Laser Manufacturer"

We found the report really useful in understanding the complex Indian market and it provided lots of high quality insights. On the basis of this we commissioned Ken to produce a bespoke follow up to answer some specific questions about our market. This is now being used to help develop our marketing and sales strategy. We were very pleased with the comprehensive coverage, detail provided and actionable insights.... "Owner, Therefore Consulting UK"


Allergic Rhinitis-Pipeline Review, H1 2015

Allergic Rhinitis-Pipeline Review, H1 2015


  Request for Sample Report

Executive Summary

Allergic Rhinitis-Pipeline Review, H1 2015

Summary

Global Markets Direct's, 'Allergic Rhinitis-Pipeline Review, H1 2015', provides an overview of the Allergic Rhinitis's therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Allergic Rhinitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Allergic Rhinitis and special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

The report provides a snapshot of the global therapeutic landscape of Allergic Rhinitis

The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities

The report reviews key players involved in the therapeutics development for Allergic Rhinitis and enlists all their major and minor projects

The report summarizes all the dormant and discontinued pipeline projects

A review of the Allergic Rhinitis products under development by companies and universities/research institutes based on information derived from company and industry-specific sources

Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages

A detailed assessment of monotherapy and combination therapy pipeline projects

Coverage of the Allergic Rhinitis pipeline on the basis of target, MoA, route of administration and molecule type

Latest news and deals relating related to pipeline products

Reasons To Buy

Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Develop strategic initiatives by understanding the focus areas of leading companies

Identify and understand important and diverse types of therapeutics under development for Allergic Rhinitis

Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

Devise corrective measures for pipeline projects by understanding Allergic Rhinitis pipeline depth and focus of Indication therapeutics

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

Table of Contents

Table of Contents 2

List of Tables 5

List of Figures 7

Introduction 8

Global Markets Direct Report Coverage 8

Allergic Rhinitis Overview 9

Therapeutics Development 10

Pipeline Products for Allergic Rhinitis-Overview 10

Pipeline Products for Allergic Rhinitis-Comparative Analysis 11

Allergic Rhinitis-Therapeutics under Development by Companies 12

Allergic Rhinitis-Therapeutics under Investigation by Universities/Institutes 16

Allergic Rhinitis-Pipeline Products Glance 17

Late Stage Products 17

Clinical Stage Products 18

Early Stage Products 19

Allergic Rhinitis-Products under Development by Companies 20

Allergic Rhinitis-Products under Investigation by Universities/Institutes 26

Allergic Rhinitis-Companies Involved in Therapeutics Development 27

3M Drug Delivery Systems 27

Adamis Pharmaceuticals Corporation 28

ALK-Abello A/S 29

AnaptysBio, Inc. 30

Axikin Pharmaceuticals, Inc. 31

BioTech Tools s.a. 32

ELORAC, Inc. 33

FAES Farma SA 34

Fountain Biopharma Inc. 35

GenMont Biotech Inc. 36

GlaxoSmithKline plc 37

Glenmark Pharmaceuticals Ltd. 38

GlycoMar Limited 39

HAL Allergy BV 40

Hanmi Pharmaceuticals, Co. Ltd. 41

Hisamitsu Pharmaceutical Co., Inc. 42

Johnson & Johnson 43

Laboratorios LETI S.L. 44

Ligand Pharmaceuticals, Inc. 45

Marinomed Biotechnologie GmbH 46

Merck & Co., Inc. 47

Mitsubishi Tanabe Pharma Corporation 48

Nektar Therapeutics 49

NeoPharm Co., Ltd. 50

Novartis AG 51

Nuvo Research Inc. 52

Ono Pharmaceutical Co., Ltd. 53

Oxagen Limited 54

Panmira Pharmaceuticals, LLC. 55

Pfizer Inc. 56

Protectimmun GmbH 57

Revance Therapeutics, Inc. 58

Rottapharm SpA 59

Shionogi & Co., Ltd. 60

Stallergenes S.A. 61

Sun Pharma Advanced Research Company Ltd. 62

Trimel BioPharma SRL 63

VentiRx Pharmaceuticals, Inc. 64

Xencor, Inc. 65

Ziarco Pharma Ltd 66

Allergic Rhinitis-Therapeutics Assessment 67

Assessment by Monotherapy Products 67

Assessment by Combination Products 68

Assessment by Target 69

Assessment by Mechanism of Action 71

Assessment by Route of Administration 73

Assessment by Molecule Type 75

Drug Profiles 77

(azelastine hydrochloride + mometasone furoate)-Drug Profile 77

(fluticasone furoate + levocabastine hydrochloride)-Drug Profile 78

(GSP 301-1 NS + GSP 301-2 NS)-Drug Profile 79

(montelukast sodium + levocetirizine dihydrochloride)-Drug Profile 80

854-A-Drug Profile 81

Allergen for Birch Pollen Induced Allergic Rhinitis and Rhinoconjunctivitis-Drug Profile 82

Allergen for House Dust Mites Induced Allergic Rhinitis and Rhinoconjunctivitis-Drug Profile 83

Allergen for Pollen Grass Allergy Induced Allergic Rhinitis and Rhinoconjunctivitis-Drug Profile 85

allergenic pollen extract of timothy-Drug Profile 86

AM-211-Drug Profile 87

AM-461-Drug Profile 89

ANB-020-Drug Profile 91

andolast-Drug Profile 92

APC-3000-Drug Profile 93

Arabinogalactan-Drug Profile 94

AVANZ Olive Immunotherapy for Allergic Rhinitis-Drug Profile 95

Avanz Phleum Pratense-Drug Profile 96

bepotastine besylate-Drug Profile 97

bilastine-Drug Profile 99

budesonide-Drug Profile 100

C-525-Drug Profile 101

CBP-174-Drug Profile 102

cidoxepin hydrochloride-Drug Profile 103

Depigoid Birch-Drug Profile 104

Dermatophagoides Pteronyssinus Allergen Extract-Drug Profile 105

desloratadine-Drug Profile 106

Drug for Japanese Cedar Pollen Allergy-Drug Profile 107

esketamine-Drug Profile 108

FB-825-Drug Profile 110

fevipiprant-Drug Profile 111

fluticasone furoate-Drug Profile 113

GLY-079-Drug Profile 116

GLY-145-Drug Profile 117

GMNL-32-Drug Profile 118

gpASIT + TM-Drug Profile 119

GSK-2245035-Drug Profile 121

HP-3060-Drug Profile 123

Lactococcus lactis G121-Drug Profile 124

levocabastine hydrochloride-Drug Profile 125

MAM-06301-Drug Profile 126

MK-8237-Drug Profile 127

NKTR-125-Drug Profile 128

NPB-3-Drug Profile 129

OC-2417-Drug Profile 130

OC-459-Drug Profile 131

Olea Europaea Pollen Extract-Drug Profile 133

ONO-4053-Drug Profile 134

PF-06444752-Drug Profile 135

PF-06444753-Drug Profile 136

rBet v1-Drug Profile 137

rE58-Drug Profile 139

RT-001-Drug Profile 140

S-524101-Drug Profile 142

S-555739-Drug Profile 144

Small Molecule for Allergic Rhinitis-Drug Profile 145

Small Molecule to Antagonize G Protein Coupled Receptors for Respiratory Disorders-Drug Profile 146

Small Molecules to Inhibit Histamine H3 Receptor for Nasal Congestion and Allergic Rhinitis-Drug Profile 147

Small Molecules to Inhibit PGD2 Synthase for Asthma and Allergic Rhinitis-Drug Profile 148

Small Molecules to Inhibit Spleen Tyrosine Kinase for Allergic Inflammatory Disorders-Drug Profile 149

SUN-0597-Drug Profile 150

SUNL-731-Drug Profile 152

TBS-6-Drug Profile 153

Vaccine for Allergic Rhinitis and Allergic Asthama-Drug Profile 154

VAK-694-Drug Profile 155

VTX-1463-Drug Profile 157

VTX-378-Drug Profile 158

WF-10-Drug Profile 159

WF-10 liposomal-Drug Profile 161

XmAb-7195-Drug Profile 162

ZPL-868087-Drug Profile 163

Allergic Rhinitis-Recent Pipeline Updates 164

Allergic Rhinitis-Dormant Projects 176

Allergic Rhinitis-Discontinued Products 183

Allergic Rhinitis-Product Development Milestones 185

Featured News & Press Releases 185

Appendix 192

Methodology 192

Coverage 192

Secondary Research 192

Primary Research 192

Expert Panel Validation 192

Contact Us 193

Disclaimer 193

List of Tables

Number of Products under Development for Allergic Rhinitis, H1 2015 15

Number of Products under Development for Allergic Rhinitis-Comparative Analysis, H1 2015 16

Number of Products under Development by Companies, H1 2015 18

Number of Products under Development by Companies, H1 2015 (Contd..1) 19

Number of Products under Development by Companies, H1 2015 (Contd..2) 20

Number of Products under Investigation by Universities/Institutes, H1 2015 21

Comparative Analysis by Late Stage Development, H1 2015 22

Comparative Analysis by Clinical Stage Development, H1 2015 23

Comparative Analysis by Early Stage Development, H1 2015 24

Products under Development by Companies, H1 2015 25

Products under Development by Companies, H1 2015 (Contd..1) 26

Products under Development by Companies, H1 2015 (Contd..2) 27

Products under Development by Companies, H1 2015 (Contd..3) 28

Products under Development by Companies, H1 2015 (Contd..4) 29

Products under Development by Companies, H1 2015 (Contd..5) 30

Products under Investigation by Universities/Institutes, H1 2015 31

Allergic Rhinitis-Pipeline by 3M Drug Delivery Systems, H1 2015 32

Allergic Rhinitis-Pipeline by Adamis Pharmaceuticals Corporation, H1 2015 33

Allergic Rhinitis-Pipeline by ALK-Abello A/S, H1 2015 34

Allergic Rhinitis-Pipeline by AnaptysBio, Inc., H1 2015 35

Allergic Rhinitis-Pipeline by Axikin Pharmaceuticals, Inc., H1 2015 36

Allergic Rhinitis-Pipeline by BioTech Tools s.a., H1 2015 37

Allergic Rhinitis-Pipeline by ELORAC, Inc., H1 2015 38

Allergic Rhinitis-Pipeline by FAES Farma SA, H1 2015 39

Allergic Rhinitis-Pipeline by Fountain Biopharma Inc., H1 2015 40

Allergic Rhinitis-Pipeline by GenMont Biotech Inc., H1 2015 41

Allergic Rhinitis-Pipeline by GlaxoSmithKline plc, H1 2015 42

Allergic Rhinitis-Pipeline by Glenmark Pharmaceuticals Ltd., H1 2015 43

Allergic Rhinitis-Pipeline by GlycoMar Limited, H1 2015 44

Allergic Rhinitis-Pipeline by HAL Allergy BV, H1 2015 45

Allergic Rhinitis-Pipeline by Hanmi Pharmaceuticals, Co. Ltd., H1 2015 46

Allergic Rhinitis-Pipeline by Hisamitsu Pharmaceutical Co., Inc., H1 2015 47

Allergic Rhinitis-Pipeline by Johnson & Johnson, H1 2015 48

Allergic Rhinitis-Pipeline by Laboratorios LETI S.L., H1 2015 49

Allergic Rhinitis-Pipeline by Ligand Pharmaceuticals, Inc., H1 2015 50

Allergic Rhinitis-Pipeline by Marinomed Biotechnologie GmbH, H1 2015 51

Allergic Rhinitis-Pipeline by Merck & Co., Inc., H1 2015 52

Allergic Rhinitis-Pipeline by Mitsubishi Tanabe Pharma Corporation, H1 2015 53

Allergic Rhinitis-Pipeline by Nektar Therapeutics, H1 2015 54

Allergic Rhinitis-Pipeline by NeoPharm Co., Ltd., H1 2015 55

Allergic Rhinitis-Pipeline by Novartis AG, H1 2015 56

Allergic Rhinitis-Pipeline by Nuvo Research Inc., H1 2015 57

Allergic Rhinitis-Pipeline by Ono Pharmaceutical Co., Ltd., H1 2015 58

Allergic Rhinitis-Pipeline by Oxagen Limited, H1 2015 59

Allergic Rhinitis-Pipeline by Panmira Pharmaceuticals, LLC., H1 2015 60

Allergic Rhinitis-Pipeline by Pfizer Inc., H1 2015 61

Allergic Rhinitis-Pipeline by Protectimmun GmbH, H1 2015 62

Allergic Rhinitis-Pipeline by Revance Therapeutics, Inc., H1 2015 63

Allergic Rhinitis-Pipeline by Rottapharm SpA, H1 2015 64

Allergic Rhinitis-Pipeline by Shionogi & Co., Ltd., H1 2015 65

Allergic Rhinitis-Pipeline by Stallergenes S.A., H1 2015 66

Allergic Rhinitis-Pipeline by Sun Pharma Advanced Research Company Ltd., H1 2015 67

Allergic Rhinitis-Pipeline by Trimel BioPharma SRL, H1 2015 68

Allergic Rhinitis-Pipeline by VentiRx Pharmaceuticals, Inc., H1 2015 69

Allergic Rhinitis-Pipeline by Xencor, Inc., H1 2015 70

Allergic Rhinitis-Pipeline by Ziarco Pharma Ltd, H1 2015 71

Assessment by Monotherapy Products, H1 2015 72

Assessment by Combination Products, H1 2015 73

Number of Products by Stage and Target, H1 2015 75

Number of Products by Stage and Mechanism of Action, H1 2015 77

Number of Products by Stage and Route of Administration, H1 2015 79

Number of Products by Stage and Molecule Type, H1 2015 81

Allergic Rhinitis Therapeutics-Recent Pipeline Updates, H1 2015 169

Allergic Rhinitis-Dormant Projects, H1 2015 181

Allergic Rhinitis-Dormant Projects (Contd..1), H1 2015 182

Allergic Rhinitis-Dormant Projects (Contd..2), H1 2015 183

Allergic Rhinitis-Dormant Projects (Contd..3), H1 2015 184

Allergic Rhinitis-Dormant Projects (Contd..4), H1 2015 185

Allergic Rhinitis-Dormant Projects (Contd..5), H1 2015 186

Allergic Rhinitis-Dormant Projects (Contd..6), H1 2015 187

Allergic Rhinitis-Discontinued Products, H1 2015 188

Allergic Rhinitis-Discontinued Products (Contd..1), H1 2015 189

List of Figures

Number of Products under Development for Allergic Rhinitis, H1 2015 15

Number of Products under Development for Allergic Rhinitis-Comparative Analysis, H1 2015 16

Number of Products under Development by Companies, H1 2015 17

Number of Products under Investigation by Universities/Institutes, H1 2015 21

Comparative Analysis by Late Stage Development, H1 2015 22

Comparative Analysis by Clinical Stage Development, H1 2015 23

Comparative Analysis by Early Stage Products, H1 2015 24

Assessment by Monotherapy Products, H1 2015 72

Assessment by Combination Products, H1 2015 73

Number of Products by Top 10 Targets, H1 2015 74

Number of Products by Stage and Top 10 Targets, H1 2015 74

Number of Products by Top 10 Mechanism of Actions, H1 2015 76

Number of Products by Stage and Top 10 Mechanism of Actions, H1 2015 76

Number of Products by Top 10 Routes of Administration, H1 2015 78

Number of Products by Stage and Top 10 Routes of Administration, H1 2015 78

Number of Products by Top 10 Molecule Types, H1 2015 80

Number of Products by Stage and Top 10 Molecule Types, H1 2015 80

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

3M Drug Delivery Systems

Adamis Pharmaceuticals Corporation

ALK-Abello A/S

AnaptysBio, Inc.

Axikin Pharmaceuticals, Inc.

BioTech Tools s.a.

ELORAC, Inc.

FAES Farma SA

Fountain Biopharma Inc.

GenMont Biotech Inc.

GlaxoSmithKline plc

Glenmark Pharmaceuticals Ltd.

GlycoMar Limited

HAL Allergy BV

Hanmi Pharmaceuticals, Co. Ltd.

Hisamitsu Pharmaceutical Co., Inc.

Johnson & Johnson

Laboratorios LETI S.L.

Ligand Pharmaceuticals, Inc.

Marinomed Biotechnologie GmbH

Merck & Co., Inc.

Mitsubishi Tanabe Pharma Corporation

Nektar Therapeutics

NeoPharm Co., Ltd.

Novartis AG

Nuvo Research Inc.

Ono Pharmaceutical Co., Ltd.

Oxagen Limited

Panmira Pharmaceuticals, LLC.

Pfizer Inc.

Protectimmun GmbH

Revance Therapeutics, Inc.

Rottapharm SpA

Shionogi & Co., Ltd.

Stallergenes S.A.

Sun Pharma Advanced Research Company Ltd.

Trimel BioPharma SRL

VentiRx Pharmaceuticals, Inc.

Xencor, Inc.

Ziarco Pharma Ltd

Allergic Rhinitis Therapeutic Products under Development, Key Players in Allergic Rhinitis Therapeutics, Allergic Rhinitis Pipeline Overview, Allergic Rhinitis Pipeline, Allergic Rhinitis Pipeline Assessment


Related Products in vertical
Other reports by publisher
Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com